Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
18 hedge funds and large institutions have $673K invested in Intellipharmaceuticals International Inc. in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.
5% less funds holding
Funds holding: 19 → 18 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
69% less capital invested
Capital invested by funds: $2.15M → $673K (-$1.48M)
98% less call options, than puts
Call options by funds: $4K | Put options by funds: $213K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FFA
First Foundation Advisors
Irvine,
California
|
+$131K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$124K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$26.8K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.04M |
| 2 |
FMBTD
First Midwest Bank Trust Division
Joliet,
Illinois
|
-$81.6K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$74K |
| 4 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$60K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$59K |
IPCI Hedge Fund Activity: Q3 2015 in Review
18 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q3 2015, worth a combined $673K — down 69% from $2.15M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of IPCI and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 3 added.
The largest buyer was First Foundation Advisors, opening a new position worth an estimated $131K. The largest seller was Tekla Capital Management, exiting entirely with an estimated $1.04M sold.
- 18 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q3 2015, down from 19 in Q2 2015.
- Funds reported $673K of Intellipharmaceuticals International Inc. stock for Q3 2015, down 69% quarter-over-quarter.
- 3 funds opened new Intellipharmaceuticals International Inc. positions in Q3 2015 and 4 closed out, a net change of -1 holder.
- The largest Intellipharmaceuticals International Inc. buyer in Q3 2015 was First Foundation Advisors, an estimated $131K added.
- The largest Intellipharmaceuticals International Inc. seller in Q3 2015 was Tekla Capital Management, an estimated $1.04M sold.
Based on aggregated 13F filings for Q3 2015.